Wells Fargo
APGNW

Wells Fargo’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Wells Fargo’s Portfolio APGNW Stock Details APGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,206
Closed -$3K – 8135
2021
Q4 		$3K Hold
8,206
– – ﹤0.01% 6841
2021
Q3 		$5K Buy
+8,206
New +$7.88K ﹤0.01% 6397

Other funds holding APGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's APGNW Position: Q1 2022 in Review

Wells Fargo sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q1 2022, closing a stake of 8,206 shares — an estimated $3K sold.

Wells Fargo first reported a position in APGNW in Q3 2021 and held it in 2 quarters. The position peaked at $5K in Q3 2021. 12 funds tracked by Wall St. Rank hold APGNW as of Q1 2022.

  • Wells Fargo reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
  • Wells Fargo sold 8,206 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q1 2022, an estimated $3K.
  • Wells Fargo first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2021 and held it in 2 quarters.
  • Wells Fargo's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $5K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q1 2022.

Based on Wells Fargo's 13F filing for Q1 2022, filed 16 May 2022.